Connection

Thomas Keane to Androgen Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Thomas Keane has written about Androgen Receptor Antagonists.
Thomas Keane
Connection Strength
0.034
Androgen Receptor Antagonists
  1. The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-na?ve Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2016 10; 70(4):675-683.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.